Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene

Oncogene

Volumn 25, Issue 9, 2006, Pages 1420-1423

  Barnache, S ^a   Le Scolan, E ^a   Kosmider, O ^a   Denis, N ^a   Moreau Gachelin, F ^a  

^a INSTITUT CURIE   (France)

Author keywords

Erythroleukemia; Erythropoietin; Phosphatidylinositol phosphatase; Transcriptional regulation

Indexed keywords

ERYTHROPOIETIN; HYDROLASE; ISOENZYME; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 4 PHOSPHATASE TYPE II; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOENGINEERING; CANCER GROWTH; CANCER STAGING; CARCINOGENICITY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ERYTHROBLAST; ERYTHROLEUKEMIA; ERYTHROPOIESIS; GENETIC TRANSCRIPTION; IN VIVO STUDY; ISOENZYME ANALYSIS; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRELEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; ERYTHROBLASTS; ERYTHROPOIETIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; MICE, TRANSGENIC; ONCOGENE PROTEIN V-AKT; PHOSPHORIC MONOESTER HYDROLASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 33644775504     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209187     Document Type: Article

References (22)

1. Barnache S, Mayeux P, Payrastre B, Moreau-Gachelin F. (2001). Blood 98: 2372-2381.
2. Celada A, Borràs FE, Soler C, Lloberas J, Klemz M, van Beveren C et al. (1996). J Exp Med 184: 61-69.
3. Hanada M, Feng J, Hemmings BA. (2004). Biochim Biophys Acta 1697: 3-16.
4. Ivetac I, Munday AD, Kisseleva MV, Zhang XM, Luff S, Tiganis T et al. (2005). Mol Biol Cell 16: 2218-2233.
5. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M et al. (1991). Cancer Res 51: 341-348.
6. Liang P, Pardee AB. (1997). Differ Display Meth Protocol 85: 3-11.
7. Maehama T, Dixon JE. (1998). J Biol Chem 273: 13375-13378.
8. Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, Grimber G et al. (1996). Mol Cell Biol 16: 2453-2463.
9. Munday AD, Norris FA, Caldwell KK, Brown S, Majerus PW, Mitchell CA. (1999). Proc Natl Acad Sci USA 96: 3640-3645.
10. Norris FA, Atkins RC, Majerus PW. (1997). J Biol Chem 272: 23859-23864.
11. Norris FA, Auethavekiat V, Majerus PW. (1995). J Biol Chem 270: 16128-16133.
12. Nystuen A, Legare ME, Shultz LD, Frankel WN. (2001). Neuron 32: 203-212.
13. Oikawa T, Yamada T, Kihara-Negishi F, Yamamoto H, Kondoh N, Hitomi Y et al. (1999). Cell Death Differ 6: 599-608.
14. Scott EW, Simon MC, Anastasi J, Singh H. (1994). Science 265: 1573-1577.
15. Song G, Ouyang G, Bao S. (2005). J Cell Mol Med 9: 59-71.
16. Tilbrook PA, Klinken SP. (1999). Int J Biochem Cell Biol 31: 1001-1005.
17. Toker A, Cantley LC. (1997). Nature 387: 673-676.
18. Vanhaesebroeck B, Alessi DR. (2000). Biochem J 346: 561-576.
19. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC et al. (2001). Annu Rev Biochem 70: 535-602.
20. Vyas P, Norris FA, Joseph R, Majerus PW, Orkin SH. (2000). Proc Natl Acad Sci USA 97: 13696-13701.
21. Wu H, Liu X, Jaenisch R, Lodish HF. (1995). Cell 83: 59-67.
22. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG et al. (1995). EMBO J 14: 2816-2826.